Cascadian Therapeutics, Inc. — Revenue by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/553a935e-be7d-40dc-a9fd-677038d127a0/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2011 | $145.0k | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-107156 |
| FY 2010 | $18.0k | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-107156 |
| FY 2009 | $2.1M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-107156 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Cascadian Therapeutics, Inc. — all facts · Net Income · Operating Income